Edition:
India

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

17.28USD
22 Jun 2018
Change (% chg)

$0.14 (+0.82%)
Prev Close
$17.14
Open
$17.18
Day's High
$17.45
Day's Low
$16.92
Volume
513,083
Avg. Vol
184,703
52-wk High
$23.00
52-wk Low
$12.86

Chart for

About

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $1,322.97
Shares Outstanding(Mil.): 59.46
Dividend: --
Yield (%): --

Financials

BRIEF-OraSure Technologies Appoints New Chief Financial Officer

* CUCA WILL SUCCEED RONALD SPAIR Source text for Eikon: Further company coverage:

04 May 2018

BRIEF-OraSure Reports Q1 Loss Per Share $0.03

* Q1 EARNINGS PER SHARE VIEW $-0.06 -- THOMSON REUTERS I/B/E/S

03 May 2018

BRIEF-Orasure Technologies Says Board Approved Appointment Of Michael Celano As Chairman

* ORASURE TECHNOLOGIES SAYS ON FEB 20, BOARD APPROVED APPOINTMENT OF MICHAEL CELANO AS CHAIRMAN, EFFECTIVE APRIL 1, 2018 - SEC FILING Source text for Eikon: (http://bit.ly/2CcOGwb) Further company coverage:

23 Feb 2018

BRIEF-Orasure Q4 Revenue Rose 47 Percent To $52 Million

* ORASURE ANNOUNCES RECORD 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS

08 Feb 2018

BRIEF-Orasure Technologies Announces Management Succession Plan

* ORASURE TECHNOLOGIES INC - BOARD OF DIRECTORS HAS APPOINTED STEPHEN S. TANG, AS CO'S NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER, EFFECTIVE AS OF APRIL 1

04 Jan 2018

Earnings vs. Estimates